Braskem S.A. ADR (BAK) Stock: Analyzing the Quarterly Movement

In the past week, BAK stock has gone down by -1.43%, with a monthly decline of -11.33% and a quarterly plunge of -37.94%. The volatility ratio for the week is 2.62%, and the volatility levels for the last 30 days are 2.97% for Braskem S.A. ADR The simple moving average for the last 20 days is -3.85% for BAK stock, with a simple moving average of -18.09% for the last 200 days.

Is It Worth Investing in Braskem S.A. ADR (NYSE: BAK) Right Now?

Additionally, the 36-month beta value for BAK is 2.04. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for BAK is 172.20M and currently, short sellers hold a 1.32% ratio of that float. The average trading volume of BAK on June 28, 2024 was 785.72K shares.

BAK) stock’s latest price update

The stock of Braskem S.A. ADR (NYSE: BAK) has decreased by -2.90 when compared to last closing price of 6.73. Despite this, the company has experienced a -1.43% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2024-06-14 that Braskem’s controlling holding, Novonor, is looking for a buyer for its stake in the company. The proposals to purchase this stake exceed the company’s current market cap by two times. For this reason, I believe that the dangerous risks, such as the sinking of Maceió, are already in the price, bringing a good opportunity.

Analysts’ Opinion of BAK

JP Morgan, on the other hand, stated in their research note that they expect to see BAK reach a price target of $11, previously predicting the price at $11.50. The rating they have provided for BAK stocks is “Neutral” according to the report published on July 05th, 2023.

BAK Trading at -13.40% from the 50-Day Moving Average

After a stumble in the market that brought BAK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.54% of loss for the given period.

Volatility was left at 2.97%, however, over the last 30 days, the volatility rate increased by 2.62%, as shares sank -11.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.80% lower at present.

During the last 5 trading sessions, BAK fell by -1.51%, which changed the moving average for the period of 200-days by -29.02% in comparison to the 20-day moving average, which settled at $6.75. In addition, Braskem S.A. ADR saw -25.91% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for BAK

Current profitability levels for the company are sitting at:

  • -0.04 for the present operating margin
  • 0.05 for the gross margin

The net margin for Braskem S.A. ADR stands at -0.09. The total capital return value is set at -0.04. Equity return is now at value -114.86, with -6.79 for asset returns.

Based on Braskem S.A. ADR (BAK), the company’s capital structure generated 0.93 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 14.15. The interest coverage ratio of the stock is -0.71.

Currently, EBITDA for the company is 1.01 billion with net debt to EBITDA at 10.07. When we switch over and look at the enterprise to sales, we see a ratio of 0.68. The receivables turnover for the company is 11.47for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.

Conclusion

In conclusion, Braskem S.A. ADR (BAK) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts